The clinical and economic impact of exacerbations of chronic obstructive pulmonary disease: a cohort of hospitalized patients.
about
COPD: the patient perspectiveHospital admissions and mortality in patients with COPD exacerbations and vertebral body compression fractures.Costs of illness analysis in Italian patients with chronic obstructive pulmonary disease (COPD): an update.LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD.Readmission for Acute Exacerbation within 30 Days of Discharge Is Associated with a Subsequent Progressive Increase in Mortality Risk in COPD Patients: A Long-Term Observational Study.Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease.Prevalence of chronic obstructive pulmonary disease in asymptomatic smokers.Inhalation errors due to device switch in patients with chronic obstructive pulmonary disease and asthma: critical health and economic issues.A year in the life of German patients with COPD: the DACCORD observational studyImpact of lung function on exacerbations, health care utilization, and costs among patients with COPDPulmonary rehabilitation coupled with negative pressure ventilation decreases decline in lung function, hospitalizations, and medical cost in COPD: A 5-year study.Rising total costs and mortality rates associated with admissions due to COPD exacerbations.Cost Analysis of Hospitalized Patients with Chronic Obstructive Pulmonary Disease: A State-Level Cross-Sectional Study.Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study.Long-Term Maintenance Bronchodilation With Indacaterol/Glycopyrrolate Versus Indacaterol in Moderate-to-Severe COPD Patients: The FLIGHT 3 Study.Uptake of telehealth implementation for COPD patients in a high-poverty, inner-city environment: A survey.Reduced COPD exacerbation risk correlates with improved FEV1: A meta-regression analysis.Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.Impact of mild exacerbation on COPD symptoms in a Japanese cohortAn update on the pharmacotherapeutic management of lower respiratory tract infections.A longitudinal assessment of sleep variables during exacerbations of chronic obstructive pulmonary disease.Trends in self-rated health status and health services use in COPD patients (2006-2012). A Spanish population-based survey.Acute exacerbated COPD: room for improvement in key elements of care.FLIGHT1 and FLIGHT2: Efficacy and Safety of QVA149 (Indacaterol/Glycopyrrolate) versus Its Monocomponents and Placebo in Patients with Chronic Obstructive Pulmonary Disease.[Outcome predictors for COPD patients hospitalized for acute exacerbation].
P2860
Q26764894-318CAB91-1DB1-42D6-AF60-80960381092EQ33838191-A4F0C651-FE97-4ECB-95A4-B89395D00401Q35194665-A23E578D-9DE5-47C4-B4EE-ACAD5BC514ECQ35703517-43E629C3-0D4B-47C0-A99C-BFD61053B180Q35946331-B289F0D1-C837-40D6-B1BF-64741AD01CCAQ36065017-2E51A158-367E-4F2B-AD66-F3A05BB624DBQ36257057-49BA62A0-70E0-49B1-82EF-19D23D03022DQ36729127-8573681D-663C-48DD-956A-1653C213F9AAQ37123265-72073FC0-CA03-46FC-A16D-959D9CBDCC7EQ37142609-FE3B3455-C9FA-45B4-8DB7-9EC02282DC9AQ37354827-AF483B84-B7D9-4104-ABF1-73E86EAF7466Q37414845-D38EBEF5-5860-4030-9A19-DCF7B98AE488Q37451998-BEC920E6-AA61-4BCE-B060-D91A03009655Q37603590-F16E2823-3C30-4290-AD60-6F3FA7A40230Q38371555-E9A8245B-267D-4332-AC2B-B4950763689CQ38781173-FC126EAD-E6E5-49FF-BC9C-13B78457A63FQ39292087-AEF03D49-0338-4DDA-B421-45DD8DA4298CQ39458622-D0931B03-D32A-4F22-AC8C-E09225AF3D08Q39646728-077014F3-A55C-4F1F-BFFB-E4285FDCFD0BQ40222424-A6574511-73A2-4C7B-80A6-CAC35B362D64Q40879566-2179113A-84AF-4A42-99C9-7568DD35E893Q41638474-ED72DF5A-822B-4980-BC54-A59994E2C619Q42688268-54B5682A-8307-45B7-BAE9-DD27AF042BDCQ50954570-43F9B39B-1B66-4200-B63D-9C865BF9AC32Q53597606-4ED5C0AC-8CB5-46E2-8006-1D0EB96FF8C4
P2860
The clinical and economic impact of exacerbations of chronic obstructive pulmonary disease: a cohort of hospitalized patients.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The clinical and economic impa ...... hort of hospitalized patients.
@ast
The clinical and economic impa ...... hort of hospitalized patients.
@en
type
label
The clinical and economic impa ...... hort of hospitalized patients.
@ast
The clinical and economic impa ...... hort of hospitalized patients.
@en
prefLabel
The clinical and economic impa ...... hort of hospitalized patients.
@ast
The clinical and economic impa ...... hort of hospitalized patients.
@en
P2093
P2860
P50
P1433
P1476
The clinical and economic impa ...... hort of hospitalized patients.
@en
P2093
Carla Fornari
Giancarlo Cesana
Virginio Chiodini
P2860
P304
P356
10.1371/JOURNAL.PONE.0101228
P407
P577
2014-06-27T00:00:00Z